Literature DB >> 14749643

Accuracy of home pregnancy tests at the time of missed menses.

Laurence A Cole1, Sarah A Khanlian, Jaime M Sutton, Suzy Davies, William F Rayburn.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the validity of home pregnancy tests (HPTs) around the time of the missed menses. STUDY
DESIGN: Levels of human chorionic gonadotropin (hCG) were determined in urine around the time of the missed menses, and 5th and 95th centiles were calculated. In a blind study evaluating 18 brands of HPTs, each was tested six times with five concentrations of hCG, 0 to 100 mIU/mL. Sensitivity was defined as the concentration at which six of six brands gave positive results, at the suggested reading time or at an extended time.
RESULTS: It was estimated that a sensitivity of 12.5 mIU/mL was needed to detect 95% of pregnancies at the time of missing menses. Only 1 of 18 HPTs had this sensitivity. If faintly discernible results considered, 2 of 18 brands gave false-positive or invalid results. Clear positive results were given by only 44% of the brands at 100 mIU/mL hCG. If one accepted faintly discernible and extended reading times, all brands responded at 100 mIU/mL. A test with 100 mIU/mL sensitivity would detect approximately 16% of pregnancies at the time of missed menses.
CONCLUSION: The utility of HPTs is questioned. Clinicians need to be aware of the limitations of current HPT brands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749643     DOI: 10.1016/j.ajog.2003.08.043

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Persistent Organochlorine Exposure and Pregnancy Loss: A Prospective Cohort Study.

Authors:  Anna Z Pollack; Germaine M Buck Louis; Courtney D Lynch; Paul J Kostyniak
Journal:  J Environ Prot (Irvine, Calif)       Date:  2011-08-01

2.  Designing prospective cohort studies for assessing reproductive and developmental toxicity during sensitive windows of human reproduction and development--the LIFE Study.

Authors:  Germaine M Buck Louis; Enrique F Schisterman; Anne M Sweeney; Timothy C Wilcosky; Robert E Gore-Langton; Courtney D Lynch; Dana Boyd Barr; Steven M Schrader; Sungduk Kim; Zhen Chen; Rajeshwari Sundaram
Journal:  Paediatr Perinat Epidemiol       Date:  2011-06-20       Impact factor: 3.980

3.  Time-varying cycle average and daily variation in ambient air pollution and fecundability.

Authors:  Carrie J Nobles; Enrique F Schisterman; Sandie Ha; Germaine M Buck Louis; Seth Sherman; Pauline Mendola
Journal:  Hum Reprod       Date:  2018-01-01       Impact factor: 6.918

Review 4.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

5.  Perceptions of an ideal point-of-care test for sexually transmitted infections--a qualitative study of focus group discussions with medical providers.

Authors:  Yu-Hsiang Hsieh; M Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill Huppert; Anne M Rompalo; Charlotte A Gaydos
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

6.  Strips of Hope: Accuracy of Home Pregnancy Tests and New Developments.

Authors:  C Gnoth; S Johnson
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

7.  A likelihood model that accounts for censoring due to fetal loss can accurately test the effects of maternal and fetal genotype on the probability of miscarriage.

Authors:  Colin I O'Donnell; Charles J Glueck; Tasha E Fingerlin; Deborah H Glueck
Journal:  Hum Hered       Date:  2008-10-17       Impact factor: 0.444

Review 8.  Urine proteomics: the present and future of measuring urinary protein components in disease.

Authors:  Jonathan Barratt; Peter Topham
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

9.  Label-Free Sensors Based on Graphene Field-Effect Transistors for the Detection of Human Chorionic Gonadotropin Cancer Risk Biomarker.

Authors:  Carrie Haslam; Samar Damiati; Toby Whitley; Paul Davey; Emmanuel Ifeachor; Shakil A Awan
Journal:  Diagnostics (Basel)       Date:  2018-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.